Friday, September 25, 2015
A dozen awards from the NIH will support research that incorporates DNA sequence information into electronic medical records. The goal of research conducted by the Electronic Medical Records and Genomics (eMERGE) network is to better understand the genomic basis of disease and to tailor medical care to individual patients based on their genomic differences.
Cost regulators in Scotland have given their endorsement to NHS Scotland use of seven new drugs including treatments for blood cancer, ovarian cancer and hepatitis C.
Citing insufficient professional guidance on how to interpret certain elements of the Physician Payments Sunshine Act, a group of seven medical writers and editors has concluded that difficulty could have a “chilling effect” on physicians’ ability to participate in clinical trials and publish results.
FDA Draft Guidance on Male-Mediated Developmental Risks for Pharmaceuticals
Although the FDA hasn’t found any systemic issues that affect the effectiveness or safety of generic medicines clinically tested at Hyderabad, India-based CRO GVK BioSciences, it is supporting the European ban of hundreds of products.
The ClinicalTrials.gov registry, which was introduced in 2000, appears to have had a noticeable impact on the number of reported positive and negative effects of heart disease treatments before and after that year, according to a recent PLoS ONE study.
People who delay or refuse vaccines for themselves or their children are presenting a growing challenge for countries seeking to close the immunization gap. Globally, one in five children still do not receive routine life-saving immunizations, and an estimated 1.5 million children still die each year of diseases that could be prevented by vaccines that already exist, according to the World Health Organization (WHO).
China has decided to reform its appraisal and approval system for drugs and medical instruments with the aim of improving drug safety and quality and encouraging innovation.